NP and GP regimen as original chemotherapy for advanced non-small cell lung cancer

Chinese Journal of Cancer Prevention and Treatment

Volumn 17, Issue 9, 2010, Pages 703-705

  Guo, Cheng Ye ^a   Yu, Jin Cai ^a   An, Zhi Jie ^a   Wang, Da Zhi ^a   Li, De Ai ^a   Tan, Ai Rong ^a  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

Antineoplastic combined chemotherapy protocols; Carcinoma, non small cell lung; Treatment outcome

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CYTOTOXICITY; DRUG EFFICACY; FEMALE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE; THROMBOCYTOPENIA;

EID: 77956203387     PISSN: 16735269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Non-small Cell Lung Cancer Co-operative Group. Chemotherapy in non-small cell lung cancer, a meta-analysis using up-dated data on individual patients from 52 randomized trials[J]. Br Med J, 1995, (31):899-909.
2. Laskin J J, Sandler A B. First-line treatment for advanced non-small cell lung cancer[J]. Oncology (Williston Park), 2005, 19(13):1671-1676.
3. Spigel D R, Greco F A. Chemotherapy in metastatic and locally advanced non-small cell lung cancer[J]. Simin Surg Oncol, 2003, 21(2):98-110. (Pubitemid 37237419)
4. Manegold C. Gemcitabine(Gemzar) in non-small cell lung cancer [J]. Expert Rev Anticanaer Ther, 2004, 4(3):345-360. (Pubitemid 38745107)
5. Belderbos J S, De Jaeger K, Heem S W D, et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional radiothrapy[J]. Radiother Oncol, 2003, 66(2):119-126.
6. Smit E F, Van Meerbeeck J P, Lianes J P, et al. Three-arm randomized study of two cisplatin-based regiments and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer, a phase III trial of the european organization for research and treatment of cancer lung cancer group-EORTC 08975[J]. J Clin Oncol, 2003, 21(21):3909-3910.